Drugs / PF-08103402
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07660731 | Jun 2026 → Jun 2027 expected | asthma | Pfizer | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-08103402 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07660731 ↗ |
| Route | Oral | “The study medicine will be taken as a suspension or tablet by mouth 1 time a day” NCT07660731 ↗ |